Hadeel Delman Najim, et al. “Influence of Adding Empagliflozin to Conventional Anti-Diabetic Therapy on Quality of Life Scale for Type 2 Diabetic Patients”. Iraqi Journal of Pharmaceutical Sciences, vol. 33, no. 3, Sept. 2024, pp. 142-9, https://doi.org/10.31351/vol33iss3pp142-149.